These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16097189)

  • 21. The politics of therapeutics.
    Somberg J
    Am J Ther; 2004; 11(6):422. PubMed ID: 15543080
    [No Abstract]   [Full Text] [Related]  

  • 22. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 23. US judge dismisses 50m dollars damages in Vioxx lawsuit.
    Charatan F
    BMJ; 2006 Sep; 333(7567):516. PubMed ID: 16960199
    [No Abstract]   [Full Text] [Related]  

  • 24. The vexations of Vioxx.
    Sibbald B
    CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046
    [No Abstract]   [Full Text] [Related]  

  • 25. Learning the value of drugs--is rofecoxib a regulatory success story?
    Eisenberg RS
    N Engl J Med; 2005 Mar; 352(13):1285-7. PubMed ID: 15800222
    [No Abstract]   [Full Text] [Related]  

  • 26. Merck VIOXX "warning" is questioned.
    Allen TS; Henderson JH
    Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent developments in health law. Merck and the Vioxx decision: playing by the changing rules of the chemical exposure game.
    Cohen JG
    J Law Med Ethics; 2005; 33(4):866-9. PubMed ID: 16686256
    [No Abstract]   [Full Text] [Related]  

  • 28. Do these doctors give medicine a black eye?
    Rice B
    Med Econ; 2003 Dec; 80(24):58-62, 65, 69. PubMed ID: 14733056
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 30. Make or break time in Vioxx drama.
    Nature; 2006 Mar; 440(7082):277. PubMed ID: 16541045
    [No Abstract]   [Full Text] [Related]  

  • 31. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx.
    Moynihan R
    BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350
    [No Abstract]   [Full Text] [Related]  

  • 32. Don't blame it all on the bogey.
    Day M
    BMJ; 2007 Jun; 334(7606):1250-1. PubMed ID: 17569929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Companies to pay $39.5m in OxyContin and Risperdal cases.
    McCarthy M
    BMJ; 2015 Dec; 351():h7018. PubMed ID: 26721284
    [No Abstract]   [Full Text] [Related]  

  • 34. Vioxx may go back on sale after scraping past FDA panel.
    Wadman M
    Nature; 2005 Feb; 433(7028):790. PubMed ID: 15729304
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 36. Manipulating a journal article.
    N Y Times Web; 2005 Dec; ():WK11. PubMed ID: 16453395
    [No Abstract]   [Full Text] [Related]  

  • 37. Causation, Vioxx, and legal issues.
    Green MD
    Science; 2005 Nov; 310(5750):973. PubMed ID: 16284163
    [No Abstract]   [Full Text] [Related]  

  • 38. US provides immunity from legal claims related to three Ebola vaccines.
    McCarthy M
    BMJ; 2014 Dec; 349():g7608. PubMed ID: 25499701
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticipating a Vioxx defense strategy: will corporate honesty be enough?
    Willis KD
    Tort Trial Insur Pract Law J; 2006; 41(4):1163-78. PubMed ID: 17091567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.